|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Yu JC, Kang WM and Ma ZQ:
Treatment strategy for early gastric cancer. Surg Oncol.
21:119–123. 2012. View Article : Google Scholar
|
|
3
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma
Y, Chen Y, Pan F, Wang K, Ni J, et al: Circulating miR-16-5p and
miR-19b-3p as two novel potential biomarkers to indicate
progression of gastric cancer. Theranostics. 5:733–745. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mendell JT: MicroRNAs: Critical regulators
of development, cellular physiology and malignancy. Cell Cycle.
4:1179–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tu K, Liu Z, Yao B, Han S and Yang W:
MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT
signaling in hepatocellular carcinoma. Int J Oncol. 48:965–974.
2016.
|
|
8
|
Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng
X and Tu K: MicroRNA-92a contributes to tumor growth of human
hepatocellular carcinoma by targeting FBXW7. Oncol Rep.
34:2576–2584. 2015.PubMed/NCBI
|
|
9
|
Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q,
Yang W, Yao Y, Liu Q and Tu K: MicroRNA-212 suppresses tumor growth
of human hepatocellular carcinoma by targeting FOXA1. Oncotarget.
6:13216–13228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao X, Li X and Yuan H: microRNAs in
gastric cancer invasion and metastasis. Front Biosci. 18:803–810.
2013. View Article : Google Scholar
|
|
11
|
Tong F, Cao P, Yin Y, Xia S, Lai R and Liu
S: MicroRNAs in gastric cancer: From benchtop to bedside. Dig Dis
Sci. 59:24–30. 2014. View Article : Google Scholar
|
|
12
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Gastroenterology. 143:35–47.e2. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mo MH, Chen L, Fu Y, Wang W and Fu SW:
Cell-free circulating miRNA biomarkers in Cancer. J Cancer.
3:432–448. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Q, Yang Z, Wang F, Hu S, Yang L, Shi Y
and Fan D: MiR-19b/20a/92a regulates the self-renewal and
proliferation of gastric cancer stem cells. J Cell Sci.
126:4220–4229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P,
Nie Y, Wu K, Shi Y and Fan D: MiR-19a/b modulate the metastasis of
gastric cancer cells by targeting the tumour suppressor MXD1. Cell
Death Dis. 5:e11442014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu K and Zhao YC: MEF2D/Wnt/β-catenin
pathway regulates the proliferation of gastric cancer cells and is
regulated by microRNA-19. Tumour Biol. Jan 13–2016.Epub ahead of
print.
|
|
17
|
Yang O, Huang J and Lin S: Regulatory
effects of miRNA on gastric cancer cells. Oncol Lett. 8:651–656.
2014.PubMed/NCBI
|
|
18
|
World Medical Association: World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tu K, Li C, Zheng X, Yang W, Yao Y and Liu
Q: Prognostic significance of miR-218 in human hepatocellular
carcinoma and its role in cell growth. Oncol Rep. 32:1571–1577.
2014.PubMed/NCBI
|
|
20
|
Park SG, Chung C, Kang H, Kim JY and Jung
G: Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3
complex through kappaB site of cyclin D1 promoter. J Biol Chem.
281:31770–31777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Petrocca F, Pilozzi E, Rapazzotti M,
Aurello P, Mercantini P, Volinia S, Ruco LP, Croce CM and Vecchione
A: MicroRNAs deregulation in gastric cancer. Cancer Res. 66:1338.
2006.
|
|
22
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bours V, Franzoso G, Azarenko V, Park S,
Kanno T, Brown K and Siebenlist U: The oncoprotein Bcl-3 directly
transactivates through kappa B motifs via association with
DNA-binding p50B homodimers. Cell. 72:729–739. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cogswell PC, Guttridge DC, Funkhouser WK
and Baldwin AS Jr: Selective activation of NF-kappa B subunits in
human breast cancer: Potential roles for NF-kappa B2/p52 and for
Bcl-3. Oncogene. 19:1123–1131. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi HJ, Lee JM, Kim H, Nam HJ, Shin HJ,
Kim D, Ko E, Noh DY, Kim KI, Kim JH, et al: Bcl3-dependent
stabilization of CtBP1 is crucial for the inhibition of apoptosis
and tumor progression in breast cancer. Biochem Biophys Res Commun.
400:396–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thornburg NJ, Pathmanathan R and
Raab-Traub N: Activation of nuclear factor-kappaB p50
homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res.
63:8293–8301. 2003.PubMed/NCBI
|
|
28
|
Pallares J, Martínez-Guitarte JL, Dolcet
X, Llobet D, Rue M, Palacios J, Prat J and Matias-Guiu X:
Abnormalities in the NF-kappaB family and related proteins in
endometrial carcinoma. J Pathol. 204:569–577. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tu K, Liu Z, Yao B, Xue Y, Xu M, Dou C,
Yin G and Wang J: BCL-3 promotes the tumor growth of hepatocellular
carcinoma by regulating cell proliferation and the cell cycle
through cyclin D1. Oncol Rep. 35:2382–2390. 2016.PubMed/NCBI
|
|
30
|
Puvvada SD, Funkhouser WK, Greene K, Deal
A, Chu H, Baldwin AS, Tepper JE and O'Neil BH: NF-κB and Bcl-3
activation are prognostic in metastatic colorectal cancer.
Oncology. 78:181–188. 2010. View Article : Google Scholar :
|
|
31
|
Liu Z, Jiang Y, Hou Y, Hu Y, Cao X, Tao Y,
Xu C, Liu S, Wang S, Wang L, et al: The IκB family member Bcl-3
stabilizes c-Myc in colorectal cancer. J Mol Cell Biol. 5:280–282.
2013. View Article : Google Scholar : PubMed/NCBI
|
